In this Oncology Brothers podcast episode, Naval Daver, MD, MD Anderson Cancer Center, Houston, Texas, discusses treatment strategies for both therapy‑related and de novo acute myeloid leukemia (AML), focusing on cases…
Tara Lin, MD, University of Kansas Medical Center, Kansas City, Kansas, discusses how she approaches choosing induction therapy for patients with treatment-related acute myeloid leukemia, emphasizing that fitness…
John Weinberg, MD, COO, Veloxis Pharmaceuticals, talks about the challenges in current organ transplantation methods, and Veloxis’ once-daily solution to advancing kidney transplantation. According to Weinberg, most kidney transplants…
Karen Shayne and Judy Pearson, Co-Founders, Women Survivors Alliance, discuss how their organization solves issues regarding current care for female cancer survivors, including: Absence of available resources for…
Jose Cavazos, MD, Professor of Medicine – Neurology & Physiology, Associate Professor of Pharmacology at University of Texas Health Science Center at San Antonio, discusses responsive neurological stimulation…
Michael Roizen, MD, Chief Wellness Officer, Cleveland Clinic, and Chief Medical Correspondent for The Dr. Oz Show discusses the importance of fish as part of a healthy diet, especially for pregnant…
Susan J. Gross, MD, Professor of Clinical Obstetrics & Gynecology and Women’s Health, Pediatrics and Genetics at the Albert Einstein College of Medicine discusses genetic disorders, comparing DNA to…
Selim R. Benbadis, MD, Director, Comprehensive Epilepsy Program, University of South Florida and Tampa General Hospital, discusses a common problem in reading EEGs: over-reading or misreading a normal…
Kourosh Parsapour, MD, MBA discusses the difficulty that patients often have in understanding and coping with disease and illness, and how new technologies can remedy this age-old obstacle. PersonalRN (pRN) is…
Susan J. Gross, MD, Professor of Clinical Obstetrics & Gynecology and Women’s Health, Pediatrics and Genetics at the Albert Einstein College of Medicine offers her insights on a few of…
Yaron Daniely, PhD, MBA, CEO of Alcobra Pharma talks about MDX, which, if approved, will be the first therapy of its kind for Fragile X Syndrome, the orphan disease…
Ermias D. Belay, MD, Associate Director for Epidemiologic Science, Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention…
